Evaluation of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  AJR. American journal of roentgenology

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2214/AJR.07.2262PMID 18430852
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of several amino acid transports and glutamine metabolism in MOLT4 human T4 leukemia cells.

  2006cited by this paper
• A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

  2006cited by this paper
• Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo

  2006cited by this paper
• Opposed-phase MRI for fat quantification in fat-water phantoms with 1H MR spectroscopy to resolve ambiguity of fat or water dominance.

  2006cited by this paper
• Choline Transport for Phospholipid Synthesis

  2006cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Etiology and functional status of liver cirrhosis by 31P MR spectroscopy.

  2005cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy.

  2005cited by this paper
• Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases

  2005cited by this paper
• Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?

  2004cited by this paper
• The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C

  2003cited by this paper
• Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies

  2003cited by this paper
• Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C

  2002cited by this paper
• MR proton spectroscopy in liver examinations of healthy individuals in vivo.

  2002cited by this paper
• Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation.

  2001cited by this paper
• Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

  2001cited by this paper
• Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings.

  2001cited by this paper
• Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey

  2000cited by this paper
• Appropriateness of liver biopsy.

  2000cited by this paper
• Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

  1999cited by this paper
• Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.

  1999cited by this paper
• Host- and disease-specific factors affecting steatosis in chronic hepatitis C.

  1998cited by this paper
• Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

  1998cited by this paper
• Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

  1998cited by this paper
• Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry

  1997cited by this paper
• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  1997cited by this paper
• Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.

  1997cited by this paper
• Histopathologic findings in chronic hepatitis C.

  1996cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• Quantification of liver fat using magnetic resonance spectroscopy.

  1994cited by this paper
• Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

  1994cited by this paper
• Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography

  1993cited by this paper
• A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.

  1993cited by this paper
• The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis

  1992cited by this paper
• A 21-year experience with major hemorrhage after percutaneous liver biopsy.

  1990cited by this paper
• A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy.

  1990cited by this paper
• The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years

  1990cited by this paper
• Nonalcoholic steatohepatitis: a study of 49 patients.

  1989cited by this paper
• Sampling variability on percutaneous liver biopsy.

  1979cited by this paper

• Autoimmune Hepatitis and Fibrosis

  2023cites this paper
• Quantitative MDCT and MRI assessment of hepatic steatosis in genotype 4 chronic hepatitis C patients with fibrosis

  2021cites this paper
• Autoimmune hepatitis: Epidemiology, prognosis and follow-up

  2019cites this paper
• Metabolic effects of hypoxia and chronic hepatitis C

  2018cites this paper
• Progress in non-invasive detection of liver fibrosis

  2018cites this paper
• 31Phosphorus magnetic resonance spectroscopy of the liver for evaluating inflammation and fibrosis in autoimmune hepatitis

  2017cites this paper
• How to Perform Selective Liver Biopsy in Living Liver Donors Using Plain Computed Tomography.

  2016cites this paper
• How to Perform Selective Liver Biopsy in Living Liver Donors Using Plain Computed Tomography

  2016cites this paper
• In vivo and ex vivo measurements: noninvasive assessment of alcoholic fatty liver using 1H-MR spectroscopy.

  2015cites this paper
• Metabolomic changes during cellular transformation monitored by metabolite–metabolite correlation analysis and correlated with gene expression

  2015cites this paper
• Chapter 3 Quantitative determination of liver triglyceride levels with 3 T 1 HMR Spectroscopy in mice with moderately elevated liver fat content

  2015cites this paper
• Diagnostic Value of MRI Proton Density Fat Fraction for Assessing Liver Steatosis in Chronic Viral C Hepatitis

  2015cites this paper
• Monitoring Fatty Liver

  2015cites this paper
• Section 1. Image Evaluation of Fatty Liver in Living Donor Liver Transplantation

  2014cites this paper
• Magnetic Resonance Spectroscopy (MRS)

  2014cites this paper
• Quantitative determination of liver triglyceride levels with 3T ¹H-MR spectroscopy in mice with moderately elevated liver fat content.

  2014cites this paper
• In vivo relaxation behavior of liver compounds at 7 tesla, measured by single‐voxel proton MR spectroscopy

  2014cites this paper
• HEPATIC FAT CONTENT ASSESSMENT USING MR-BASED METHODS

  2014cites this paper
• In vivo 1H‐MRS hepatic lipid profiling in nonalcoholic fatty liver disease: An animal study at 9.4 T

  2013cites this paper
• MAGNETIC RESONANCE SPECTROSCOPY (MRS) FOR EVALUATION OF NEUROLOGICAL DISORDERS

  2012cites this paper
• Performance of magnetic resonance elastography and diffusion‐weighted imaging for the staging of hepatic fibrosis: A meta‐analysis

  2012cites this paper
• Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.

  2012cites this paper
• MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients

  2011cites this paper
• Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging.

  2011cites this paper
• Hepatic fat-content assessment using magnetic resonance-based methods

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Applications of magnetic resonance spectroscopy for noninvasive assessment of hepatic steatosis

  2011cites this paper
• Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.

  2010cites this paper
• Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study.

  2010cites this paper
• Imaging-based quantification of hepatic fat: methods and clinical applications.

  2009cites this paper
• Review of Magnetic Resonance Spectroscopy in the Liver and the Pancreas

  2009cites this paper
• Parametric exploration of the liver by magnetic resonance methods

  2009cites this paper
• Imaging-based Quanti- fi cation of Hepatic Fat: Methods and Clinical

  2009cites this paper
• Current Awareness in NMR in Biomedicine

  2008cites this paper
• Magnetic Resonance Spectroscopy (mrs) Magnetic Resonance Spectroscopy (mrs) Medicare & Medicaid Coverage Rationale Medicare Has a National Coverage Determination for Magnetic Resonance Spectroscopy (220.2.1) Indications and Limitations of Coverage Nationally Non-covered Indications

  year unknowncites this paper